"The over-the-counter trading market of the Düsseldorf Stock Exchange has included Cannovum AG, pharmaceutical wholesaler and manufacturer of high-quality medical cannabis products based in Berlin, in May 2021 - a direct listing of the shares of previous shareholders."
"Cannovum is the first German listed medical cannabis company and therefore has a lot of pioneering work to do. Cannovum wants to set itself apart from the competition with sustainable and organic production. Sun-ripened cannabis without pesticides: this unique selling point is what Marten wants to make the industry standard in a few years."
"It is important for us to apply the knowledge we have gained in the medical segment to the consumer segment. This includes the quality of the product on offer. We would like to see pharmaceutical grade quality in the over-the-counter cannabis market as well."